<DOC>
	<DOCNO>NCT01471834</DOCNO>
	<brief_summary>The purpose clinical investigation verify efficacy safety CVRx Barostim Neo System treatment resistant hypertension .</brief_summary>
	<brief_title>Barostim Neo System Treatment Resistant Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Age least 21 year 80 year Resistant hypertension despite optimal , stable antihypertensive medication least 4 week Significant carotid plaque stenosis Known suspect baroreflex failure autonomic neuropathy Significant renal disease require dialysis Myocardial infarction , unstable angina , syncope , cerebral vascular accident within past 3 month Secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>